advertisement
Antioxidants (Basel, Switzerland) 30
Showing records 1 to 25 |
Display all abstracts in Antioxidants (Basel, Switzerland)107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal DiseasesMohtashami Z
Antioxidants (Basel, Switzerland) 2023; 12:
107882 Profiling the miRNA from Exosomes of Non-Pigmented Ciliary Epithelium-Derived Identifies Key Gene Targets Relevant to Primary Open-Angle GlaucomaPattabiraman PP
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic StatusRamos Rego I
Antioxidants (Basel, Switzerland) 2023; 12:
107883 m6A Modification-Association with Oxidative Stress and Implications on Eye DiseasesNi Y
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE PathwayNaguib S
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic StatusSilvério D
Antioxidants (Basel, Switzerland) 2023; 12:
107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal DiseasesSingh MK
Antioxidants (Basel, Switzerland) 2023; 12:
107883 m6A Modification-Association with Oxidative Stress and Implications on Eye DiseasesZhang H
Antioxidants (Basel, Switzerland) 2023; 12:
107882 Profiling the miRNA from Exosomes of Non-Pigmented Ciliary Epithelium-Derived Identifies Key Gene Targets Relevant to Primary Open-Angle GlaucomaFeinstein V
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE PathwayDeJulius CR
Antioxidants (Basel, Switzerland) 2023; 12:
107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal DiseasesNeto FT
Antioxidants (Basel, Switzerland) 2023; 12:
107882 Profiling the miRNA from Exosomes of Non-Pigmented Ciliary Epithelium-Derived Identifies Key Gene Targets Relevant to Primary Open-Angle GlaucomaBeit-Yannai E
Antioxidants (Basel, Switzerland) 2023; 12:
107883 m6A Modification-Association with Oxidative Stress and Implications on Eye DiseasesChu L
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic StatusEufrásio MI
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE PathwayBackstrom JR
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic StatusPinhanços SS
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE PathwayHaider AA
Antioxidants (Basel, Switzerland) 2023; 12:
107883 m6A Modification-Association with Oxidative Stress and Implications on Eye DiseasesZhao Y
Antioxidants (Basel, Switzerland) 2023; 12:
107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal DiseasesSalimiaghdam N; Hasanpour H
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE PathwayAng JM
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic StatusLopes da Costa B; Lopes da Costa B
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE PathwayBoal AM
Antioxidants (Basel, Switzerland) 2023; 12:
107884 Mitochondrial Open Reading Frame of the 12S rRNA Type-c: Potential Therapeutic Candidate in Retinal DiseasesKenney MC
Antioxidants (Basel, Switzerland) 2023; 12:
107881 TRAP1 Is Expressed in Human Retinal Pigment Epithelial Cells and Is Required to Maintain their Energetic StatusTeixeira J
Antioxidants (Basel, Switzerland) 2023; 12:
108223 Intraocular Sustained Release of EPO-R76E Mitigates Glaucoma Pathogenesis by Activating the NRF2/ARE PathwayCalkins DJ
Antioxidants (Basel, Switzerland) 2023; 12: